Management of Atopic Dermatitis in the Pediatric Population

  title={Management of Atopic Dermatitis in the Pediatric Population},
  author={Andrew C Krakowski and Lawrence F. Eichenfield and Magdalene A. Dohil},
  pages={812 - 824}
Atopic dermatitis, one of the most common skin disorders in young children, has a prevalence of 10% to 20% in the first decade of life. It is a chronic illness that requires a multifaceted treatment strategy in the setting of limited therapeutic options. Balancing safety concerns with efficacious treatment is of particular importance in the pediatric population. Parents of patients with atopic dermatitis turn to their primary caregivers for guidance regarding this physically demanding and… 

Tables from this paper

Management of Patients with Atopic Dermatitis: The Role of Emollient Therapy

The role of emollients in the management of atopic dermatitis, with particular emphasis on infants and young children, is discussed.

Atopic dermatitis in children.

Making GPs confident and knowledgeable about atopic dermatitis will make the interaction between the practitioner, families and children more rewarding, and to reduce their concerns regarding the long-term side effects of topical corticosteroids.

2014 update on atopic dermatitis in children

There have been several recent breakthroughs in the diagnosis, pathophysiology, and management of AD, but much work is still needed in order to ensure optimal care for AD sufferers.

Mild to Moderate Atopic Dermatitis : A Guide to Therapeutic Selection

  • Medicine
  • 2010
pattern, atopic dermatitis (AD) affects individuals of all ages, although its prevalence is highest in children. While the pathophysiology of AD is not yet fully understood, genetically-based

Atopic Dermatitis: Skin-Directed Management

The goal of this report is to assist pediatricians with accurate and useful information that will improve the care of patients with atopic dermatitis.

Atopic dermatitis

  • W. WatsonS. Kapur
  • Medicine
    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
  • 2011
Successful management of the disorder requires a multifaceted approach that involves education, optimal skin care practices, anti-inflammatory treatment with topical corticosteroids and/or topical calcineurin inhibitors, the use of first-generation antihistamines to help manage sleep disturbances, and the treatment of skin infections.

Pediatric Atopic Dermatitis: A Review of the Medical Management

Emollients are recommended in pediatric patients with a diagnosis of atopic dermatitis regardless of symptoms, and topical corticosteroids reduce the inflammation and pruritus associated with atopy dermatitis and are available in several formulations and strengths.

Management of Atopic Dermatitis: The Role of Tacrolimus

Tacrolimus belongs to the class of calcineurin inhibitors, which is a type of immunomodulator possessing promising efficacy in treating AD, and is an effective and safe non-corticosteroid substitute treatment for AD.

Atopic dermatitis

Successful management of the disorder requires a multifaceted approach that involves education, optimal skin care practices, anti-inflammatory treatment with topical corticosteroids and/or topical calcineurin inhibitors, the management of pruritus, and the treatment of skin infections.

Atopic Dermatitis: Skin-Directed Management abstract

New data support the theory that AD results from primary abnormalities of the skin barrier,11 suggesting that skin-directed management of AD is of paramount importance.



Pediatric atopic dermatitis: should we treat it differently?

The purpose of the present study is to highlight important educational and therapeutic strategies designed to optimally care for this patient population.

Tacrolimus ointment: utilization patterns in children under age 2 years.

Conservative treatment in young children with atopic dermatitis often fails in this age group and frequently patients are treated with TCS, antibiotics, and antihistamines.

Systematic review of treatments for atopic eczema.

An up-to-date coverage 'map' of randomised controlled trials (RCTs) of treatments of atopic eczema is produced to assist in making treatment recommendations by summarising the available RCT evidence using qualitative and quantitative methods.

Atopic dermatitis and the atopic march.

Consensus conference on pediatric atopic dermatitis.

Infection in atopic dermatitis

  • D. Leung
  • Medicine, Biology
    Current opinion in pediatrics
  • 2003
Recent studies suggest that the skin of patients with atopic dermatitis has increased avidity for binding to Staphylococcus aureus and is deficient in its ability to generate antimicrobial peptides needed to eradicate infectious agents.

Systemic therapy of atopic dermatitis

Immunosuppressants, immune response modifiers, antihistamines and antibiotics are among the classes of systemic medications frequently used to treat extensive atopic dermatitis; the indications and scientific support for the use of these and other less commonly used medications will be reviewed.

Prednicarbate emollient cream 0.1% in pediatric patients with atopic dermatitis.

Prednicarbate emollient cream 0.1% was found to be safe and effective for the treatment of atopic dermatitis in pediatric patients for up to 3 weeks and resulted in improvements based on global evaluations and sign/symptom scores.

Effects of Atopic Dermatitis on Young American Children and Their Families

The comprehensive conceptual framework summarizes the ways in which atopic dermatitis affects the quality of life in young American children and forms the basis from which quality-of-life instruments can be developed.